IF: 0.478
Cite Score:
0.54
THOMSON REUTERS - SCOPUS

Accuracy of MRI in Rectal Cancer After Preoperative Neoadjuvant Chemoradiotherapy

AUTHORS

Saeed Naghibi 1

AUTHORS INFORMATION

1 Islamic Azad University

Warning: No corresponding author defined!

ARTICLE INFORMATION

Iranian Journal of Radiology: 14 (Special Issue); e47965
Published Online: April 12, 2017
Article Type: Abstract
Received: December 20, 2016
Accepted: February 7, 2017
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: About 1/4 colorectal cancers are related to the rectum. There 40.000 patients with the mean age of 50 years diagnosed with rectal cancer in USA. The symptoms are in a wide spectrum such as rectal bleeding, changing of defecation habits, pain, incontinenecy in the case of esphincter invasion. The diagnosis depends on getting a detailed history and a physical examination. For years the main treatment of rectal cancer was abdominoperineal resection with permanent clostomy. Todays treatment plan includes less invasive surgical techniques combined with neoadjuvant chemoradiotherapy which results in less recurrent rates. MRI is a reliable modality in staging primary tumors but there has been conflicts about its accuracy for restaging after neoadjuvant chemoradiotherapy. In this study, accuracy, sensitivity and specifity of MRI will be discussed.

Methods: Study on 34 patients diagnosed with rectal adenocarcinoma referred to oncology clinic was conducted. The treatment plan included 4050 cGY radiotherapy and 5FU, Xeloda chemotherapy. All patients were assessed with 1/5 T MRI 6 to 8 weeks after treatment. T1 and T2 images with sagittal, cronal and axial planes with and without contrast agent were obtained and interpreted by two radiologists and compared with pathologic specimens as a gold standard.

Results: The demographic information was: mean age of 65/26 years, 19 men (55/9%), 15 women (44/1%). Accuracy of MRI at T and N staging were 38/2 % and 61/8% with the highest sensitivity of T3NM0 and specifity of T1N2.

Conclusions: MRI can be used for assessing rectal tumors and restaging after preoperative chemoradiotherapy.

Keywords

MRI-Rectal Cancer-Neoadjuvant Radiochemotherapy

© 2017, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: